These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38270308)

  • 1. m
    Wen Q; Wang S; Hong L; Shen S; He Y; Sheng X; Zhuang X; Chen S; Wang Y; Zhuang H
    Immun Inflamm Dis; 2024 Jan; 12(1):e1150. PubMed ID: 38270308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m5C methylation modification guides the prognostic value and immune landscapes in acute myeloid leukemia.
    Liu Y; Chen Y; Cai M; Hong Y; Wu X; Li S
    Aging (Albany NY); 2023 Sep; 15(18):9858-9876. PubMed ID: 37751592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m
    Liao X; Chen L; Liu J; Hu H; Hou D; You R; Wang X; Huang H
    Epigenetics; 2023 Dec; 18(1):2160134. PubMed ID: 36567510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA m
    Zhang Q; Sun X; Sun J; Lu J; Gao X; Shen K; Qin X
    Front Immunol; 2022; 13():905057. PubMed ID: 36389669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-methylcytosine RNA modification regulators-based patterns and features of immune microenvironment in acute myeloid leukemia.
    Ding Y; Bajpai AK; Wu F; Lu W; Xu L; Mao J; Li Q; Pan Q; Lu L; Wang X
    Aging (Albany NY); 2024 Jan; 16(3):2340-2361. PubMed ID: 38277218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration in acute myeloid leukemia.
    Han S; Qi J; Fang K; Wang H; Tang Y; Wu D; Han Y
    Cancer Med; 2022 Mar; 11(5):1413-1426. PubMed ID: 35023630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
    Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W
    Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of N6-Methyladenosine (m
    Liu D; Yuan M; Wang Z; Sun L; Fang Y; Ma X; Zhang L; Xing Y; Zhu J; Liu Y; Zhu W; Bao S; Jia Y; Wang Y
    Can J Gastroenterol Hepatol; 2022; 2022():3506518. PubMed ID: 36452120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m
    Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
    Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m
    Li F; Deng Q; Pang X; Huang S; Zhang J; Zhu X; Chen H; Liu X
    Front Oncol; 2021; 11():729887. PubMed ID: 34804923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hub ten gene-based risk score system using RNA m
    Yuan B; Liu W; Huo M; Zhang J; Yang Y; Gao T; Yin X; Yang T; Teng X; Huang W; Yu H
    Breast Cancer; 2022 Jul; 29(4):645-658. PubMed ID: 35174450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.
    Yu G; Bao J; Zhan M; Wang J; Li X; Gu X; Song S; Yang Q; Liu Y; Wang Z; Xu B
    Front Immunol; 2022; 13():914577. PubMed ID: 35757739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of m5C RNA Modification Patterns in Biochemical Recurrence and Tumor Microenvironment Characterization of Prostate Adenocarcinoma.
    Xu Z; Chen S; Zhang Y; Liu R; Chen M
    Front Immunol; 2022; 13():869759. PubMed ID: 35603206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of m
    Wang X; Mao Y; Xu H; Chen J; Chen X
    Heliyon; 2023 Sep; 9(9):e19680. PubMed ID: 37809908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m5C regulator-mediated methylation modification phenotypes characterized by distinct tumor microenvironment immune heterogenicity in colorectal cancer.
    Chen Z; Li Q; Lin Y; Lin S; Gao J; Chen S
    Sci Rep; 2023 Jul; 13(1):11950. PubMed ID: 37488178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of m6A modification patterns and development of m6A-hypoxia prognostic signature to characterize tumor microenvironment in triple-negative breast cancer.
    Shen X; Zhong J; He J; Han J; Chen N
    Front Immunol; 2022; 13():978092. PubMed ID: 36105819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of m6A methylation modifications and tumor microenvironment infiltration in thyroid cancer.
    Ji FH; Yang Z; Sun C; Lowe S; Qiu XG
    Clin Transl Oncol; 2023 Jan; 25(1):269-282. PubMed ID: 36163443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M
    Chen H; Ge XL; Zhang ZY; Liu M; Wu RY; Zhang XF; Xu LP; Cheng HY; Sun XC; Zhu HC
    Transl Lung Cancer Res; 2021 May; 10(5):2172-2192. PubMed ID: 34164268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cuproptosis identified immune microenvironment and prognosis in acute myeloid leukemia.
    Luo D; Liu S; Luo J; Chen H; He Z; Gao Z; Wen Z; Liu X; Xu N
    Clin Transl Oncol; 2023 Aug; 25(8):2393-2407. PubMed ID: 36826709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m5C regulator-mediated modification patterns and tumor microenvironment infiltration characterization in colorectal cancer: One step closer to precision medicine.
    Chen B; Xi Y; Zhao J; Hong Y; Tian S; Zhai X; Chen Q; Ren X; Fan L; Xie X; Jiang C
    Front Immunol; 2022; 13():1049435. PubMed ID: 36532062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.